Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

Lancet

Volumn 357, Issue 9251, 2001, Pages 165-168

  Umans Eckenhausen, Marina A W ^a,b   Defesche, Joep C ^b   Sijbrands, Eric J G ^b   Scheerder, Robert L J M ^a   Kastelein, John J P ^b  

^a Foundation for the Identification of Persons with Inherited Hypercholesterolemia   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; DNA; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE PREDISPOSITION; DNA DETERMINATION; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; SCREENING TEST;

EID: 0035915685     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03587-X     Document Type: Article

References (20)

1. Familial hyperecholesterolemia
2. Mortality in treated heterozygous familial hypercholesterolemia: Implications for clinical management
3. Cholesterol reduction yields clinical benefit: Impact of statin trials
4. Familial Hyperholesterolemia (FH)
5. Molecular genetic testing for familial hypercholesterolemia: Spectrum of LDL receptor gene mutations in the Netherlands
6. Diagnosing hypercholesterolemia in childhood by measuring serum cholesterol
7. Paediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment
8. DNA screening of hyperlipidemic Afrikaners for familial hypercholesterolemia
9. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
10. Familial hypercholesterolemia: A molecular, biochemical and clinical characterization of a French-Canadian pediatric population
11. Neonatal diagnosis of familial hypercholesterolemia in new-borns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia
12. Familial hypercholesterolemia: Potential diagnostic value of mutation screening in a pediatric population of South Africa
13. Familial Hypercholesterolaemia
14. 100 is clinically indistinguishable from familial hypercholesterolemia
15. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without the use of preparative ultra centrifugation
16. Total and HDL-cholesterol levels in The Netherlands: 1987-1992 - Levels and changes over time in relation to age, gender and educational level
17. Molecular biology of arrhythmic syndromes
18. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genome amplicons
19. Experience in prenatal testing for Huntington's disease in The Netherlands: Procedures, results and guidelines (1987-1997)
20. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolemia